Efficacy and Safety of HSK39297 in Anti-C5 Treated PNH Patients With Anemia

NCT07052838 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

36

Enrollment

INDUSTRY

Sponsor class

Conditions

Paroxysmal Nocturnal Haemoglobinuria (PNH)

Interventions

DRUG: HSK39297 tablets

Sponsor

Haisco Pharmaceutical Group Co., Ltd.